Securetech Innovations, Inc. 8-K

What Happened
SecureTech Innovations, Inc. filed an 8-K on April 2, 2026 disclosing that on March 31, 2026 its board nominated Brian Zucker, CPA (age 64), to serve as an independent director and as a member of the Audit Committee. The nomination is conditional: Mr. Zucker’s appointment will only become effective once (i) the Company’s common stock is approved for listing on the NASDAQ Capital Market and such listing is effective, and (ii) the Company obtains directors’ and officers’ liability insurance (D&O) at levels satisfactory to the Board. Until both conditions are met, Mr. Zucker is not deemed a director for any purpose, including Section 16 reporting or NASDAQ rules.

Key Details

• Nomination date: March 31, 2026; 8-K filed April 2, 2026.
• Committees (upon effectiveness): Audit Committee, Compensation Committee, Nomination Committee.
• Background: Over 30 years in accounting/financial operations; current CFO/Financial Operations Principal for multiple broker-dealers and hedge funds; former roles at Deloitte, Price Waterhouse, and senior positions at several public companies (e.g., Atlantis Business Development Corp., Natcore Solar, American Frontier Financial); current independent director at NanoViricides, Inc.
• Credentials: Certified Public Accountant (NY, NJ); FINRA registrations include Series 7, 24, 27, 53, 63, 79, 99; BS in Public Accounting from Pace University.
• Corporate governance notes: Board has determined Mr. Zucker will qualify as independent upon effectiveness; no related-party transactions or family relationships reported; no compensatory arrangement has been finalized—Company will disclose any compensation in an amendment or later 8-K.
• The Company issued a press release on March 31, 2026 announcing the nomination.

Why It Matters
For investors, this filing signals a board governance move tied to two milestones the company is pursuing: a NASDAQ Capital Market listing and obtaining D&O insurance. Mr. Zucker’s accounting and broker-dealer experience and expected Audit Committee role are relevant to oversight of financial reporting and regulatory compliance. Because the appointment is conditional, investors should not treat Mr. Zucker as a current director until the NASDAQ listing and D&O coverage are finalized, and should watch for follow-up filings disclosing his compensation or the effective appointment.